STANDARD BIOTOOLS INC. (LAB) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Standard Biotools Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Standard Biotools Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $128 K, a 51.3% decline year-over-year.
  • Standard Biotools Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $317 K.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2023 was $452 K.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.83 M, a 36% increase from 2021.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2021 was -$4.42 M, a 309% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $317 K $128 K -$135 K -51.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $452 K -$162 K -$232 K -331% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $684 K $50 K +$763 K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$79 K $301 K +$1.91 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.99 M $263 K +$837 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2.83 M $70 K +$883 K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$3.71 M -$713 K +$709 K +49.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$4.42 M -$1.61 M -$1.1 M -212% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$3.33 M -$574 K +$1.1 M +65.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$4.42 M -$813 K -$1.8 M -182% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$2.62 M -$1.42 M -$1.18 M -485% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.44 M -$517 K +$628 K +54.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$2.07 M -$1.67 M -$991 K -146% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$1.08 M $987 K +$633 K +179% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$1.71 M -$243 K +$925 K +79.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$2.64 M -$1.15 M -$2 K -0.18% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$2.64 M -$680 K -$722 K -1719% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$1.92 M $354 K +$594 K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 -$2.51 M -$1.17 M -$388 K -49.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$2.12 M -$1.14 M -$939 K -460% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$1.18 M $42 K +$1.23 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$2.41 M -$240 K -$318 K -408% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$2.09 M -$780 K -$45 K -6.12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$2.04 M -$204 K +$623 K +75.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$2.67 M -$1.18 M +$597 K +33.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$3.26 M $78 K +$2.18 M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$5.44 M -$735 K -$426 K -138% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$5.02 M -$827 K +$195 K +19.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$5.21 M -$1.78 M -$1.02 M -134% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$4.19 M -$2.1 M -$1.9 M -929% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$2.3 M -$309 K +$53 K +14.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$2.35 M -$1.02 M -$756 K -284% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.59 M -$762 K -$119 K -18.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$1.48 M -$204 K +$684 K +77% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$2.16 M -$362 K +$354 K +49.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$2.51 M -$266 K +$862 K +76.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$3.38 M -$643 K +$1.5 M +70% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.88 M -$888 K -$930 K -2214% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$3.95 M -$716 K -$758 K -1805% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$3.19 M -$1.13 M -$1.14 M -7620% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$2.04 M -$2.14 M -$2.18 M -5739% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $137 K $42 K +$7 K +20% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $130 K $42 K -$19 K -31.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $149 K $15 K +$14 K +1400% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $135 K $38 K -$1 K -2.56% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $136 K $35 K -$1 K -2.78% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $137 K $61 K +$41 K +205% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $96 K $1 K* -$61 K -98.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $157 K $39 K -$9 K -18.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $166 K $36 K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $20 K +$33 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $62 K -$79 K -56% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $48 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$13 K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $141 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.